“Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial”, Swiss Med Wkly, vol. 146, no. 0102, p. w14274, Jan. 2016, doi: 10.4414/smw.2016.14274.